16-28866159-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001387430.1(SH2B1):c.65C>A(p.Pro22Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000406 in 1,552,354 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001387430.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH2B1 | NM_001387430.1 | c.65C>A | p.Pro22Gln | missense_variant | 1/8 | ENST00000684370.1 | NP_001374359.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH2B1 | ENST00000684370.1 | c.65C>A | p.Pro22Gln | missense_variant | 1/8 | NM_001387430.1 | ENSP00000507475.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000655 AC: 10AN: 152646Hom.: 0 AF XY: 0.0000839 AC XY: 7AN XY: 83392
GnomAD4 exome AF: 0.0000407 AC: 57AN: 1400272Hom.: 1 Cov.: 38 AF XY: 0.0000463 AC XY: 32AN XY: 691606
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74294
ClinVar
Submissions by phenotype
SH2B1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 02, 2024 | The SH2B1 c.65C>A variant is predicted to result in the amino acid substitution p.Pro22Gln. This variant has been reported as compound heterozygous with c.806G>T (p.Gly269Val) of uncertain significance in a Palestinian individual with severe early-onset obesity (case P30 on Table 3, Mohammed et al. 2023. PubMed ID: 37329217). This variant is reported in 0.015% of alleles in individuals of Latino descent in gnomAD V2. However, in gnomAD v4 (available only on GRCh38), this variant is reported in 0.11% (5/4568) in individuals of Middle Eastern ancestry including one homozygous. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.65C>A (p.P22Q) alteration is located in exon 2 (coding exon 1) of the SH2B1 gene. This alteration results from a C to A substitution at nucleotide position 65, causing the proline (P) at amino acid position 22 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at